PortfoliosLab logoPortfoliosLab logo
NVAX vs. VERU
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NVAX vs. VERU - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Novavax, Inc. (NVAX) and Veru Inc. (VERU). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NVAX achieves a 33.93% return, which is significantly lower than VERU's 42.06% return. Over the past 10 years, NVAX has underperformed VERU with an annualized return of -23.62%, while VERU has yielded a comparatively higher -13.72% annualized return.


NVAX

1D
0.00%
1M
-2.28%
YTD
33.93%
6M
32.35%
1Y
42.63%
3Y*
10.34%
5Y*
-45.80%
10Y*
-23.62%

VERU

1D
2.70%
1M
29.36%
YTD
42.06%
6M
31.03%
1Y
-50.97%
3Y*
-35.44%
5Y*
-48.29%
10Y*
-13.72%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NVAX vs. VERU - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NVAX
Novavax, Inc.
33.93%-16.42%67.50%-53.31%-92.81%28.30%2,701.76%-89.18%48.39%-1.59%
VERU
Veru Inc.
42.06%-67.10%-9.65%-86.36%-10.36%-31.91%158.21%139.29%22.81%25.27%

Correlation

The correlation between NVAX and VERU is 0.34, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.34

Correlation (3Y)
Calculated over the trailing 3-year period

0.24

Correlation (5Y)
Calculated over the trailing 5-year period

0.28

Correlation (10Y)
Calculated over the trailing 10-year period

0.22

Correlation (All Time)
Calculated using the full available price history since Feb 11, 1999

0.15

The correlation between NVAX and VERU shifts across timeframes, from 0.15 (all time) to 0.34 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

NVAX:

$1.47B

VERU:

$65.83M

EPS

NVAX:

-$0.52

VERU:

-$0.78

PS Ratio

NVAX:

2.55

VERU:

178.51

Total Revenue (TTM)

NVAX:

$596.34M

VERU:

$303.45K

Gross Profit (TTM)

NVAX:

$504.72M

VERU:

-$57.90K

EBITDA (TTM)

NVAX:

-$57.01M

VERU:

-$8.20M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Novavax, Inc.

Veru Inc.

Return for Risk

NVAX vs. VERU — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVAX
NVAX Risk / Return Rank: 6464
Overall Rank
NVAX Sharpe Ratio Rank: 6363
Sharpe Ratio Rank
NVAX Sortino Ratio Rank: 6666
Sortino Ratio Rank
NVAX Omega Ratio Rank: 6262
Omega Ratio Rank
NVAX Calmar Ratio Rank: 6565
Calmar Ratio Rank
NVAX Martin Ratio Rank: 6464
Martin Ratio Rank

VERU
VERU Risk / Return Rank: 2222
Overall Rank
VERU Sharpe Ratio Rank: 2323
Sharpe Ratio Rank
VERU Sortino Ratio Rank: 2323
Sortino Ratio Rank
VERU Omega Ratio Rank: 2424
Omega Ratio Rank
VERU Calmar Ratio Rank: 1515
Calmar Ratio Rank
VERU Martin Ratio Rank: 2424
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NVAX vs. VERU - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Novavax, Inc. (NVAX) and Veru Inc. (VERU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NVAXVERUDifference
Sharpe ratioReturn per unit of total volatility

+1.08

Sortino ratioReturn per unit of downside risk

+1.81

Omega ratioGain probability vs. loss probability

1.16

0.96

+0.21

Calmar ratioReturn relative to maximum drawdown

1.19

-0.73

+1.92

Martin ratioReturn relative to average drawdown

2.30

-0.90

+3.19

NVAX vs. VERU - Sharpe Ratio Comparison

The current NVAX Sharpe Ratio is 0.62, which is higher than the VERU Sharpe Ratio of -0.45. The chart below compares the historical Sharpe Ratios of NVAX and VERU, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

NVAX vs. VERU - Drawdown Comparison

The maximum NVAX drawdown since its inception was -98.82%, roughly equal to the maximum VERU drawdown of -99.12%. Use the drawdown chart below to compare losses from any high point for NVAX and VERU.


Loading charts...

Drawdown Indicators


NVAXVERUDifference

Max Drawdown

Largest peak-to-trough decline

-98.82%

-99.12%

+0.30%

Max Drawdown (1Y)

Largest decline over 1 year

-35.94%

-69.93%

+33.99%

Max Drawdown (3Y)

Largest decline over 3 years

-74.11%

-88.32%

+14.21%

Max Drawdown (5Y)

Largest decline over 5 years

-98.61%

-99.12%

+0.51%

Max Drawdown (10Y)

Largest decline over 10 years

-98.82%

-99.12%

+0.30%

Current Drawdown

Current decline from peak

-97.19%

-98.72%

+1.53%

Average Drawdown

Average peak-to-trough decline

-70.78%

-54.11%

-16.67%

Ulcer Index

Depth and duration of drawdowns from previous peaks

18.59%

56.95%

-38.36%

Volatility

NVAX vs. VERU - Volatility Comparison

The current volatility for Novavax, Inc. (NVAX) is 23.73%, while Veru Inc. (VERU) has a volatility of 71.62%. This indicates that NVAX experiences smaller price fluctuations and is considered to be less risky than VERU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NVAXVERUDifference

Volatility (1M)

Calculated over the trailing 1-month period

23.73%

71.62%

-47.89%

Volatility (6M)

Calculated over the trailing 6-month period

52.56%

78.08%

-25.52%

Volatility (1Y)

Calculated over the trailing 1-year period

68.58%

113.11%

-44.53%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

105.98%

137.04%

-31.06%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

115.57%

112.82%

+2.75%

Dividends

NVAX vs. VERU - Dividend Comparison

Neither NVAX nor VERU has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

NVAX vs. VERU - Financials Comparison

This section allows you to compare key financial metrics between Novavax, Inc. and Veru Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


-500.00M0.00500.00M20222023202420252026
139.51M
56.39K
(NVAX) Total Revenue
(VERU) Total Revenue
Values in USD except per share items

Frequently Asked Questions


NVAX and VERU have a correlation of 0.34, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

VERU has higher volatility (71.62%) compared to NVAX (23.73%). In terms of maximum drawdown, NVAX dropped -98.82% vs VERU's -99.12%.

NVAX currently has the higher Sharpe Ratio (0.62 vs -0.45), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NVAX and VERU

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer